Immunocore Holdings plc (IMCR)
Largest Insider Buys in Sector
IMCR Stock Price History Chart
IMCR Stock Performance
About Immunocore Holdings plc
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase …
Insider Activity of Immunocore Holdings plc
Over the last 12 months, insiders at Immunocore Holdings plc have bought $0 and sold $9M worth of Immunocore Holdings plc stock.
On average, over the past 5 years, insiders at Immunocore Holdings plc have bought $0 and sold $9M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, Immunocore Holdings plc
| 2024-04-01 | Sale | CHIEF HR OFFICER | 4,375 0.0171% | $64.06 | $280,263 | -42.41% | ||
| 2024-02-28 | Sale | HEAD OF R&D | 36,509 0.1529% | $68.59 | $2.5M | -46.50% | ||
| 2024-02-27 | Sale | HEAD OF R&D | 54,938 0.2377% | $70.86 | $3.89M | -47.38% | ||
| 2024-02-26 | Sale | HEAD OF R&D | 28,553 0.1232% | $70.65 | $2.02M | -47.75% | ||
| 2024-01-03 | Sale | Chief HR Officer | 4,375 0.0187% | $69.89 | $305,781 | -44.13% |